A Randomized Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Formulation of KADIAN (2 x 10mg) Capsules Compared to a KADIAN 20 mg Capsule in Healthy Adult Subjects Under Fasted Conditions.

Trial Profile

A Randomized Two-Way Crossover, Single-Dose, Open-Label Study to Evaluate the Bioequivalence of a Test Formulation of KADIAN (2 x 10mg) Capsules Compared to a KADIAN 20 mg Capsule in Healthy Adult Subjects Under Fasted Conditions.

Completed
Phase of Trial: Phase I

Latest Information Update: 02 Sep 2009

At a glance

  • Drugs Morphine (Primary)
  • Indications Pain
  • Focus Pharmacokinetics
  • Sponsors Alpharma
  • Most Recent Events

    • 02 Sep 2009 Primary outcome amended as reported by ClinicalTrials.gov.
    • 10 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top